Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q9UIJ5 (Rec)
 58,342 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The antibacterial effects of a combination of tiamulin and chlortetracycline in vitro against a number of field isolates of Pasteurella multocida, Haemophilus pleuropneumoniae and Bordetella bronchiseptica were examined. There was a marked synergism between the two antibiotics against all eight isolates of P multocida, against seven of nine isolates of H pleuropneumoniae and against the single strain of B bronchiseptica tested. Two field trials were carried out on a herd with a history of complicated enzootic pneumonia where the presence of Mycoplasma hyopneumoniae and P multocida had been established and subsequently the presence of H pleuropneumoniae was discovered. Feed containing tiamulin at 100 ppm combined with chlortetracycline at 300 ppm was given for seven days to pigs affected with pneumonia, and the results were compared with untreated controls and pigs receiving chlortetracycline at 300 ppm. There was a follow-up observation period of three weeks when all groups received unmedicated feed. During the medication period the combination treated groups showed a statistically significant increase in average daily weight gain of 156 g (20.4 per cent) and in feed conversion efficiency of 0.576 (20.8 per cent) and a numerical improvement in average disease score in comparison with the untreated controls. These improvements were approximately double those observed in the groups treated with 300 ppm chlortetracycline which showed improvements of 93 g (12.2 per cent) in average daily gain and 0.301 (10.9 per cent) in feed conversion efficiency. During the following three weeks most of the initial gains were lost, probably owing to the reinfection of the treated groups by the untreated controls.
Vet Rec 1986 Aug 02
PMID:The synergistic activity of tiamulin and chlortetracycline: in-feed treatment of bacterially complicated enzootic pneumonia in fattening pigs. 375 Jul 92

An epidemiological study of atrophic rhinitis was carried out in four pig herds. Observations were made of (i) infection with Bordetella bronchiseptica and Pasteurella multocida, (ii) the presence of brachygnathia superior (BS score), (iii) the extent (grade) of turbinate atrophy and pneumonia at slaughter and (iv) growth rates from two to 16 weeks of age and average daily weight gains to slaughter. In two of the herds with no history of atrophic rhinitis, B bronchiseptica and non-toxigenic strains of P multocida were isolated; only one of 47 pigs (2 per cent) had a BS score greater than +10 mm and the most severe turbinate atrophy observed in 21 pigs at slaughter was grade 3. In contrast, from two herds with atrophic rhinitis, toxigenic strains of P multocida were isolated as well as B bronchiseptica and non-toxigenic P multocida. BS scores of greater than +10 mm were present in six of 47 pigs (13 per cent) of which five were infected with toxigenic P multocida and had severe turbinate atrophy of grade 4 or 5. There was no significant reduction in growth rates in the affected compared with the unaffected herds nor in the affected compared with the unaffected pigs in the same herd. Neither was there a correlation between progressive disease and the extent of pneumonia found at slaughter. It was concluded that in field cases of the disease, high BS scores plus severe turbinate atrophy were associated with infection by toxigenic type-D strains of P multocida.
Vet Rec 1984 Dec 15
PMID:Epidemiological study of Pasteurella multocida and Bordetella bronchiseptica in atrophic rhinitis. 652

During pregnancy seven minimum-disease sows (group A) were infected intranasally with Bordetella bronchiseptica, fed with the killed bacterium periodically and inoculated parenterally with a dead vaccine eight, six and two weeks before parturition. Groups B and C, isolated from A until farrowing, contained respectively six sows given the vaccine parenterally and eight control sows. At parturition, group A had much higher average agglutinin titres in the serum and colostrum than B or C. Group A sows gave their piglets a better passive protection against infection with B bronchiseptica strain 293 and its effects in the respiratory tract during the first eight weeks of life, especially in those exposed to spontaneous infection with bordetellae from a littermate deliberately inoculated intranasally 24 hours after birth. Passive antibody strongly affected the capacity of piglets to respond actively to parenteral vaccination (when seven and 28 days old), marked humoral responses being noted only in those from group C sows. Vaccination of piglets exposed to infection by contact reduced neither the prevalence or intensity of the nasal infection, the amount of turbinate atrophy or pneumonia nor significantly improved weight gain compared with unvaccinated littermates. Unlike their eight-week-old littermates there was little hypoplasia and no pneumonia in infected pigs (whether vaccinated or not) when they reached five months of age.
Vet Rec 1982 May 22
PMID:Immunisation of pigs against experimental infection with Bordetella bronchiseptica. 711 61

Bordetella bronchiseptica was eliminated from the nasal cavity of experimentally infected piglets after about three weeks by trimethoprim and sulphadiazine (potentiated sulphonamide) in the drinking water in two experiments (at levels of 13.3 and 66.7 micrograms per ml, respectively). The rhinitis and turbinate damage associated with the infection was significantly less when the animals were examined at seven weeks of age but daily weight gain was not improved to a significant extent compared with controls. Smaller quantities of potentiated sulphonamide were less active but no amount induced resistance in the bordetellae during the one month period of treatment.
Vet Rec 1981 Feb 14
PMID:Treatment of experimental Bordetella bronchiseptica infection in young pigs with potentiated sulphonamide in the drinking water. 726 93

Three distinct patterns of infection with Bordetella (Alcaligenes) bronchiseptica were found in groups of 12 to 24 pigs born in 1977-78 in 12 herds in southern England. In five of these, heavy bordetella infection of a substantial proportion of unweaned piglets persisted to a variable extent until slaughter. Clinical disease and severely atrophied turbinates were most marked in these groups. In three other herds the infection first appeared soon after weaning and occasionally persisted until slaughter. Clinical disease occurred in only one of these other groups and conchal atrophy at slaughter was moderate. In the groups of the four remaining herds there was no clinical disease and conchal atrophy at slaughter was slight, infection appearing only late in the weaning, or even the fattening, stages. These varying patterns suggest that immunological phenomena were involved in the infection in the least affected herds and that such responses might, if reproducible artificially, provide a better means of control of this disease in badly affected herds than the available forms of chemotherapy.
Vet Rec 1980 Jan 12
PMID:Clinical bacteriological and epidemiological observations on infectious atrophic rhinitis of pigs in southern England. 736 96

A field trial was conducted to assess the value of medicated early weaning for obtaining pigs free from some of the pathogens endemic in their herd of origin. The trial comprised 51 sows from a closed herd, which were farrowed in an isolated farrowing house in seven separate groups. The sows in each group were bred at the same time and induced to farrow on the same day. Their thriftiest piglets were weaned at five days of age and moved to an isolated early-weaning unit. At about six weeks of age they were moved to one of three isolated grow-out units where they were held to slaughter weight. Sows in five of the groups were dosed with high levels of tiamulin and trimethoprim-sulphonamide preparations from their entry into the farrowing house until their biggest piglets were weaned. Their piglets were dosed with similar drugs from birth until 10 days of age. The first and seventh groups of sows and their litters were not medicated. Tests were carried out on pigs aged five to 11 weeks, on slaughter pigs, and on pigs which died or were killed at different ages, for Mycoplasma hyopneumoniae, Bordetella bronchiseptica and colonic treponemes, which were readily detectable in the herd of origin. No evidence could be found of mycoplasma or bordetella. Colonic treponemes were recovered from some of the pigs at slaughter, but not from younger pigs. Thirty-seven boars and gilts from the medicated groups were introduced into 11 herds thought to be free of enzootic pneumonia and 13 were introduced into three herds which had enzootic pneumonia. No subsequent signs of enzootic pneumonia were noted in 10 of the enzootic pneumonia-free herds.
Vet Rec 1980 Feb 09
PMID:Medicated early weaning to obtain pigs free from pathogens endemic in the herd of origin. 744 26

Examination of pigs (eight to 10 per farm) slaughtered between December 1978 and March 1979 at abattoirs in southern England indicated that infection with Bordetella bronchiseptica was widespread. The organism was recovered from the nasal cavity of 424 out of 844 (50 per cent) of such pigs and these were distributed among 79 out of 86 (91 per cent) of the herds submitting animals. The sensitivity to sulphonamide or potentiated sulphonamide of 255 of these strains was determined: in 20 out of 70 (25 per cent) herds there was partial or complete resistance to the former drug and, in 16 out of 79 (20 per cent), to the latter also. Despite this general level of infection and bacterial resistance the prevalence and severity of turbinate atrophy was less than in a survey undertaken by others in 1974. Thus about 74 per cent of pigs had no or minor atrophy only and about 10 per cent severe lesions. Some 10 per cent of the farms sent groups in which the majority of the pigs had severe atrophy.
Vet Rec 1980 Aug 16
PMID:The prevalence of Brodetella bronchiseptica and turbinate (conchal) atrophy in English pig herds in 1978-79. 744 92

Four eight-week-old cats, shown to be free from feline calicivirus, feline herpesvirus and Chlamydia psittaci were challenged with an aerosol of Bordetella bronchiseptica. Within five days the cats developed signs of respiratory disease, characterised by nasal discharge, sneezing, spontaneous or induced coughing and dry or wet rales at auscultation. These signs were present for about 10 days, after which they began to resolve. To test the protective capacity of an experimental fimbrial antigen-based subunit vaccine, 10 kittens were vaccinated twice, with two weeks between the vaccinations, and five kittens were left unvaccinated. Two weeks after the booster the 15 kittens were challenged with an aerosol of B bronchiseptica as the sole pathogen. On the day of challenge the vaccinated kittens had a mean bordetella antibody titre of 2(9.5) whereas the control cats remained seronegative (titre < 2(2)). The control cats developed signs of respiratory disease after challenge, whereas the vaccinated cats were almost completely protected. The degrees of protection against rhinitis, sneezing, spontaneous or induced coughing, and dry or wet rales at auscultation were 100 per cent, 95 per cent, 95 per cent and 100 per cent, respectively. Furthermore, the vaccinated kittens cleared the challenge bacteria more quickly than the controls, resulting in a reduction of 80 per cent on days 15 and 18 after challenge and a reduction of 99 per cent on days 22 and 29 after challenge. The results show that B bronchiseptica can act as a primary pathogen in cats and that a vaccine containing the fimbrial antigen induces a protective immune response.
Vet Rec 1993 Sep 11
PMID:Feline bordetellosis: challenge and vaccine studies. 823 48

One-week-old Large White piglets were weaned and allocated to 14 experimental groups, each composed of five animals. Each group was housed in a separate Rochester exposure chamber and exposed continuously to gaseous ammonia at either 0, 5, 10, 15, 25, 35, or 50 ppm (two groups per exposure level). One week after ammonia exposure commenced, the pigs from one group at each exposure level were inoculated intranasally with 9 x 10(7) CFU of Pasteurella multocida type D. After a further 4 weeks of exposure, all the pigs were euthanized and the extent of turbinate degeneration was assessed by using a morphometric index (J.T. Done, D. H. Upcott, D. C. Frewin, and C. N. Hebert, Vet. Rec. 114:33-35, 1984) and a subjective scoring system (Ministry of Agriculture, Fisheries and Food, Atrophic Rhinitis: a System of Snout Grading, 1978). Exposure to ammonia at a concentration of 5 ppm or greater resulted in a significant increase in the severity of turbinate atrophy induced by P. multocida compared with that occurring in pigs kept in 0 ppm of ammonia. This effect was maximal at 10 ppm but decreased progressively at concentrations above 25 ppm. Regression analysis revealed a significant relationship between the severity of turbinate degeneration and the number of P. multocida organisms isolated from the nasal epithelium at the end of the experiment (R2 = 0.86). These findings suggest that exposure to ammonia facilitates the growth and/or survival of P. multocida within the upper respiratory tract of the pig, thereby contributing to the severity of the clinical disease atrophic rhinitis. Furthermore, exposure of pigs to ammonia at 10 ppm or greater, in the absence of either P. multocida or Bordetella bronchiseptica, induced a mild but statistically significant degree of turbinate atrophy. The findings of this study demonstrate that exposure to ammonia, at concentrations within the range encountered commonly in commercial piggeries, contributes to the severity of clinical lesions associated with atrophic rhinitis.
 ...
PMID:Synergistic role of gaseous ammonia in etiology of Pasteurella multocida-induced atrophic rhinitis in swine. 886 82

A multicentre, controlled, randomised and blinded study was carried out in three French pig herds to assess the efficacy of doxycycline administered in the feed for the control of pneumonia. About 20 per cent of 363 pigs from the three fattening units were diseased at the start of the study. Pneumonic lesions were found on pigs examined postmortem and Pasteurella multocida was isolated from the lungs of pigs in all the herds. Mycoplasma hyopneumoniae infection was confirmed either by detection in pneumonic lungs or by seroconversion in pigs sampled three weeks apart. P multocida, Bordetella bronchiseptica and Actinobacillus pleuropneumoniae were isolated from 64 per cent, 50 per cent and 2 per cent, respectively, of 148 nasal swabs. The following variables were significantly different between the treated and untreated groups (P < or = 0.001): the incidence of diseased pigs during the three weeks from the start of treatment (8.1 per cent in treated group v 35.4 per cent in control group), mean daily weight gain over the same period (934 g/day in the treated group v 834 g/day in the control group) and the cure rate of pigs which were diseased at the start of treatment (73.5 per cent in treated group v 35.3 per cent in control group). These data demonstrate that an average dose of 11 mg doxycycline/kg bodyweight per day in feed for eight days was effective in controlling pneumonia due to P multocida and M hyopneumoniae in these fattening pigs.
Vet Rec 1998 Sep 05
PMID:Efficacy of doxycycline in feed for the control of pneumonia caused by Pasteurella multocida and Mycoplasma hyopneumoniae in fattening pigs. 978 19


<< Previous 1 2 3 4 Next >>